Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells

Aurora-A Expression Is Independently Associated with Chromosomal Instability in Colorectal Cancer

(2015) Yoshifumi Baba et al.   NEOPLASIA

Aurora A Is a Repressed Effector Target of the Chromatin Remodeling Protein INI1/hSNF5 Required for Rhabdoid Tumor Cell Survival

(2011) S. Lee et al.   CANCER RESEARCH

Aurora kinase A as a rational target for therapy in glioblastoma

(2010) Valerie N. Barton et al.   Journal of Neurosurgery-Pediatrics

Claudin 6 Is a Positive Marker for Atypical Teratoid/Rhabdoid Tumors

(2009) Diane K. Birks et al.   BRAIN PATHOLOGY

Unique Molecular Characteristics of Pediatric Myxopapillary Ependymoma

(2009) Valerie N. Barton et al.   BRAIN PATHOLOGY

Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance

(2009) Rui Wang et al.   CLINICAL BIOCHEMISTRY

Aurora kinase inhibitors

(2009) J.J.E.M. Kitzen et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Polo and Aurora kinases—lessons derived from chemical biology

(2008) Stephen Taylor et al.   CURRENT OPINION IN CELL BIOLOGY

Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor

(2008) Susan N. Chi et al.   JOURNAL OF CLINICAL ONCOLOGY

Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors

(2008) Sharon L. Gardner et al.   PEDIATRIC BLOOD & CANCER